Unconfigured Ad

Collapse
This topic is closed.
X
X
 
  • Time
  • Show
Clear All
new posts
  • seqprone
    Junior Member
    • Oct 2015
    • 9

    #1

    What does the “log2(fold change)” in the gene differential expression testing result

    What does the “log2(fold change)” in the gene differential expression testing result mean?

    A) Its the log-ratio of FPKM values for a pair of expressed genes.
    B) Its the log-ratio between mapped and unmapped reads.
    C) It indicates genes with significantly different expression profiles.

    I thought it was C but it turned out to be wrong. Please help!
  • dpryan
    Devon Ryan
    • Jul 2011
    • 3478

    #2
    A fold change is, by definition, a ratio, thus it can't be C. While one could look at the ratio between mapped and unmapped reads, that wouldn't make any sense in terms of differential expression, thus it can't be B. Consequently, it must be A, which is one was of getting a log2FC, though in reality one shouldn't use FPKMs (that will hopefully be a different lecture).

    Comment

    • Michael.Ante
      Senior Member
      • Oct 2011
      • 127

      #3
      Hi seqprone,

      The log2(fold-change) is the log-ratio of a gene's or a transcript's expression values in two different conditions.
      While comparing two conditions each feature you analyse gets (normalised) expression values. This value can be zero and thus lead to undefined ratios.
      The differential expression is computed with a statistical test including not only the ratio but also the variance in the samples and other parameters.
      Cheers,
      Michael

      Comment

      • seqprone
        Junior Member
        • Oct 2015
        • 9

        #4
        Thank you for the answers!

        unfortunately, I still didn't get the right answer.

        Both A and C are wrong =(

        for the question :

        What does the “log2(fold change)” in the gene differential expression testing result mean?

        A) Its the log-ratio of FPKM values for a pair of expressed genes.
        B) Its the log-ratio between mapped and unmapped reads.
        C) It indicates genes with significantly different expression profiles.


        The answer options are:

        A
        C
        A and C
        B

        Since both C and A are wrong, I'm left with either (B) or (A&C).

        If it helps, the data we're talking about is Cuffdiff output (in tabular format) as generate by Galaxy as given below.

        test_id XLOC_000001
        gene_id XLOC_000001
        gene -
        locus chr1:224139222-224139367
        sample_1 CD20
        sample_2 H1hesc
        status OK
        value_1 15194.90
        value_2 1391.60
        log2(fold_change) -3.44877
        test_stat -49.5206
        p_value 0.0508
        q_value 0.0820411
        significant no

        Comment

        • dpryan
          Devon Ryan
          • Jul 2011
          • 3478

          #5
          Presumably whoever made the test mistakenly believes the answer to be "A and C". Note that that's actually wrong. Whoever wrote the test doesn't know enough to have done so.

          Comment

          • seqprone
            Junior Member
            • Oct 2015
            • 9

            #6
            Ok! I'll try A&C but as a concept, I'll keep what you said in mind. It's one thing to score on a multiple choice quiz and another to know the 'right answer'. Thank you so much again for your help!

            Comment

            Latest Articles

            Collapse

            • SEQadmin2
              Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
              by SEQadmin2



              Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

              Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
              ...
              10-14-2026, 09:55 AM
            • SEQadmin2
              New Genomics Technologies Take Aim at Long-Standing Limits
              by SEQadmin2


              Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

              We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
              ...
              09-28-2026, 10:25 AM

            ad_right_rmr

            Collapse

            News

            Collapse

            Topics Statistics Last Post
            Started by SEQadmin2, 10-22-2026, 11:13 AM
            0 responses
            29 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-22-2026, 10:48 AM
            0 responses
            22 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-15-2026, 10:52 AM
            0 responses
            38 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-14-2026, 05:39 AM
            0 responses
            45 views
            0 reactions
            Last Post SEQadmin2  
            Working...